Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
January 2017 onwards
Submit An Event
Events - May 2014
High Content Analysis
14 May 2014 - 15 May 2014 - Barcelona, Spain
SELECTBIO is pleased to present the 11th High Content Analysis conference, which will take place at the Fira Barcelona, on May 14th & 15th 2014. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in high content technologies and their applications.
Hot topics to be covered include novel 3D cell based screening methods, the use of model organisms, and live cell imaging approaches. Focus will also be given to the evolving use of microfluidics in this field. Attending this event will provide you with excellent opportunities for networking with like-minded peers, helping you to find solutions and build collaborations.
Anthony Davies, Director, High Content Research Facility, National Center for High Content Screening and Analysis (INCHA)
Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center
Running alongside the High Content Analysis conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip:
Advances in qPCR & dPCR
Advances in NGS & Big Data
, Advances in Automation & Robotics and
Advances in Cellular Assays & Cell Culture
You can present your research on a poster while attending the meeting.
Deadline: 02 May 2014
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Symmetry is Key to Collagen
Researchers describe how symmetry may be the key to growing collagen fibres outside the body.
Lose Weight, Escape the Eight: Weight-Based Cancer Risk
IARC has identified eight additional cancer sites linked to overweight and obesity.
Unravelling the Metastatic Mechanism of Melanoma
Research has uncovered the mechanism of melanoma spreading; the findings could lead to a cure for the disease.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,900+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!